Integrum AB – ESG risk research and ESG rating
We at sustainAX have ESG risk researched and ESG risk rated Integrum AB and our clients can access the reseach on their Bloomberg terminals.
Integrum AB is in the materiality based sector of PHARMA, BIOTECH AND LIFE SCIENCES.
About the company:
Integrum is a medical technology company listed on Nasdaq First North in Stockholm that develops and markets systems for skeletal anchored amputation prostheses. With operations carried out in fourteen countries and having been active in the market for over 20 years, the company has a world-leading position in the field. Integrum's unique OPRA TM Implant System helps improve the quality of life for amputees worldwide. The positive effects associated with bone-anchored prostheses have been demonstrated in several clinical studies. In addition, Integrum conducts groundbreaking research in related technology areas and has, among other things, developed techniques for mind-controlled prostheses and treatment of phantom limb pain.
Are you interested in the ESG research and ESG rating?
If you are interested in the ESG risk research and ESG risk rating of Integrum AB, contact us at sustainAX